Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control
ProMOC
1 other identifier
observational
20
1 country
1
Brief Summary
The key objective of the study is to gain an understanding of the biochemical processes that contribute to orthokeratology lenses being more effective in specific individuals compared to others. With this knowledge, we hope to optimize treatment effectiveness in those currently experiencing less favorable outcomes from treatment in the future. The primary aim is to investigate differences in protein levels in children using orthokeratology lenses with various effects of myopia control. Hypothesis: There is a significant difference in the expression of molecules in children with various effects of myopia control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2024
CompletedFirst Posted
Study publicly available on registry
October 17, 2024
CompletedStudy Start
First participant enrolled
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
March 10, 2026
March 1, 2026
1.5 years
October 15, 2024
March 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in protein levels measured by mass spectrometry label-free quantification (LFQ) between children using orthokeratology lenses with different levels of myopia control effectiveness
At baseline
Eligibility Criteria
Children who are currently being treated with orthokeratology lenses at the Ophthalmic Department, Vejle Hospital, University Hospital of Southern Denmark.
You may qualify if:
- Children treated with orthokeratology lenses.
- Children on or above the 95th percentile of myopia growth curves for European children at the time of treatment initiation.
- Treatment and follow-up duration ≥ 6 months.
You may not qualify if:
- Current use of eye drops.
- Objective signs of dry eyes on slit-lamp examination.
- Active eye infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vejle Hospitallead
- University of Aarhuscollaborator
Study Sites (1)
Øjenafdelingen, Vejle Sygehus
Vejle, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2024
First Posted
October 17, 2024
Study Start
November 15, 2024
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 10, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share